Arovella Therapeutics Limited logo

Arovella Therapeutics Limited (ALA)

Market Open
ASX ASX
163.04M Market Cap
- P/E Ratio
- Div Yield
668,363 Volume
- Eps
Want to track ALA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Name Time Cons. EPS Eps
Arovella Therapeutics Limited logo
ALA Arovella Therapeutics Limited
25 Feb 2026
-
-
Arovella Therapeutics Limited logo
ALA Arovella Therapeutics Limited
18 Aug 2025
-
-
Arovella Therapeutics Limited logo
ALA Arovella Therapeutics Limited
26 Feb 2025
-
-
Arovella Therapeutics Limited logo
ALA Arovella Therapeutics Limited
29 Oct 2024
-
-
Arovella Therapeutics Limited logo
ALA Arovella Therapeutics Limited
29 Aug 2024
-
-
Arovella Therapeutics Limited logo
ALA Arovella Therapeutics Limited
31 Jul 2024
-
-
Arovella Therapeutics Limited logo
ALA Arovella Therapeutics Limited
23 May 2024
-
-
Arovella Therapeutics Limited logo
ALA Arovella Therapeutics Limited
21 Feb 2024
-
-
Arovella Therapeutics Limited logo
ALA Arovella Therapeutics Limited
27 Oct 2023
-
-
Arovella Therapeutics Limited logo
ALA Arovella Therapeutics Limited
22 Sep 2016
-
-
Arovella Therapeutics Limited logo
ALA Arovella Therapeutics Limited
29 Feb 2016
-
-

ALA Earnings Reports FAQ

What is the earnings per share (EPS) for ALA?

EPS data for ALA is currently not available, as Arovella Therapeutics Limited has not reported recent earnings.

What is the company's earnings growth rate?

Arovella Therapeutics Limited has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.

When is the next earnings release date?

Arovella Therapeutics Limited has not announced its next earnings release date.

What were the most recent quarterly earnings?

The most recent quarterly earnings for Arovella Therapeutics Limited are not available at this time.

What is the price-to-earnings (P/E) ratio?

There is no P/E ratio for ALA at this time, as Arovella Therapeutics Limited has no recent EPS data to calculate it.